Welcome
Support Centre
10 February 2012 
ISRCTN Register - International Standard Randomized Controlled Trial Number
Trial registration
Unique identification scheme
International databases
home  |   my details  |   ISRCTN Register  |   mRCT  |   links  |   information  |   press
Find trials
ISRCTN Register
tips on searching

Registration
New application
Updating record

Information
introduction
governing board
ISRCTN FAQs
data set
letter of agreement
request information
guidance notes

[ Print-friendly version ]
Conservative Treatment for Tennis Elbow
ISRCTN ISRCTN65048343
ClinicalTrials.gov identifier
Public title Conservative Treatment for Tennis Elbow
Scientific title
Acronym N/A
Serial number at source N0284183280
Study hypothesis 1.To investigate whether muscle function (EMG) and thermal changes show a relationship with pain/inflammation
2. To investigate the immediate effects on muscle function using EMG and on inflammation using thermographic analysis in the different treatment groups.
3. To investigate the sustainability of EMG and thermographic changes in the different treatment groups.
4. To determine whether EMG and thermography can be altered solely by the alieviation of pain/inflammation through injection and ultrasound alone or physiotherapy rehabilitation.
5. To evaluate whether therapy resistant patients I.e. patients who do not respond to treatment can be differentiated from non resistant cases through EMG studies and thermographic analysis.
6. To develop prognostic indications for patients with tennis elbow.
Lay summary
Ethics approval Not provided at time of registration
Study design Prospective randomised, assessor-blinded trial
Countries of recruitment United Kingdom
Disease/condition/study domain Musculoskeletal Diseases: Tennis elbow
Participants - inclusion criteria 1. Patients referred to physiotherapy with tennis elbow.
2. Diabetics but diagnosis will be noted, any person satisfying the diagnostic criteria who has not had active treatment for the condition within one month and who has had symptoms for less than 18 months at first assessment with established symptoms and suitable for either treatment
3. Age 35 to 65 years.
Participants - exclusion criteria Abnormal x-rays including calcific tendonitis, glenohumeral OA, 50% loss of passive glenohumeral joint movement, normal x-rays (non symptomatic radiological AC joint arthritis accepted)
Anticipated start date 01/07/2006
Anticipated end date 01/10/2009
Status of trial Completed
Patient information material
Target number of participants 30 patients in each group
Interventions All patients referred with tennis elbow to the Trust will be assessed by the chief investigator in a standardised manner according to defined eligibility criteria. The only intervention is a 10 minute questionnaire.

Group 1 = Exercise class
Group 2 = Individual physio
Group 3 = Supervised classes (at home)
Primary outcome measure(s) The primary outcome measure is constant score for the three groups will be compared at three months to assess whether there is any difference in the recovery at this point.
Secondary outcome measure(s) The VAS and OSS scores will be analysed at three months for differences between the three groups. All three scores will be analysed at six months and two years to see if there is any differences in the groups in the longer term.
Sources of funding Wrightington, Wigan and Leigh NHS Trust

Trial website
Publications
Contact name Ms  Jeanette  Tonks
  Address Physio Department
Royal Albert Edward Infirmary
Wigan Lane
  City/town Wigan
  Zip/Postcode WN1 2NN
  Country United Kingdom
  Tel +44 01942 822103
  Fax +44
  Email Jeanette.Williams@wiganlhs-tr.nwest.nhs.uk
Sponsor Record Provided by the NHSTCT Register - 2007 Update - Department of Health
  Address The Department of Health, Richmond House, 79 Whitehall
  City/town London
  Zip/Postcode SW1A 2NL
  Country United Kingdom
  Tel +44 (0)20 7307 2622
  Fax +44
  Email dhmail@doh.gsi.org.uk
  Sponsor website: http://www.dh.gov.uk/Home/fs/en
Date applied 28/09/2007
Last edited 05/11/2007
Date ISRCTN assigned 28/09/2007
Submit your trial protocol
Submit to Trials journal
Follow us on Twitter
© 2012 ISRCTN unless otherwise stated.


BioMed Central